drugset / Trial / NCT00018278
Electrophysiologic Measures of Treatment Response in Alzheimer Disease
Non-randomizedCrossoverOpen-labelTreatment
Summary
The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response.
Timeline
- Start
- 1998-10
- Primary completion
- —
- Completion
- 2001-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | — | — |
| Subject | Nicoderm Patch | Unknown | — | Other |
| Subject | Rivastigmine | Small molecule | — | — |